Tuesday - March 17, 2026

Projecting the Global Artificial Intelligence (AI) in Remote Patient Monitoring Market Size to Expand at a 27.13% CAGR Through 2034, DelveInsight Analysis

Artificial Intelligence (AI) in Remote Patient Monitoring Market Insights, Competitive Landscape, and Market Forecast – 2034” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The growth of … Continue reading

Night Vision Disturbances Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Ocuphire Pharma, Viatris

The Key Night Vision Disturbances Companies in the market include – Ocuphire Pharma/Viatris, and others.   DelveInsight’s “Night Vision Disturbances Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Night Vision Disturbances, historical and forecasted epidemiology … Continue reading

FilingsIQ.ai Launches AI-Powered SEC Filings Analysis Platform for RIAs and Investment Analysts

New fintech tool turns 300-page 10-Ks into structured investment theses in seconds, giving independent advisors enterprise-grade research intelligence at a fraction of the cost DARIEN, CT – March 13, 2026 – https://filingsiq.ai, a new AI-powered investment researchplatform, today announced its public launch, … Continue reading

New Course from IM Dominator Responds to Growing Demand for Practical AI Agent Training Among Independent Marketers

OpenClaw Quickstart addresses the transition from reactive AI tools to autonomous AI agents, a shift that has accelerated significantly across internet marketing communities in 2025 and 2026. As interest in autonomous AI agent platforms continues to expand beyond enterprise and … Continue reading

Dermatomyositis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Octapharma, Argenx, AstraZeneca, Bristol-Myers Squibb Company, Pfizer Inc., Octapharma AG, Corbus Pharma, Holdings

The Key Dermatomyositis Companies in the market include – Octapharma, Argenx, AstraZeneca Plc., Bristol-Myers Squibb Company, Pfizer Inc., Octapharma AG, Corbus Pharmaceuticals, Holdings, Inc., Ermium Therapeutics, Kezar Life Sciences Inc., Néovacs, Horizon Therapeutics plc, Priovant Therapeutics, Inc., Corbus Pharmaceuticals, CSL … Continue reading

Congenital Adrenal Hyperplasia Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight| Becton, Dickinson and Company, Cook Medical, Cooper Surgical

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Congenital Adrenal Hyperplasia pipeline constitutes 5+ key companies continuously working towards developing 8+ Congenital Adrenal Hyperplasia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading